Literature DB >> 26593428

ATP is not involved in α1-adrenoceptor-mediated vasoconstriction in resistance arteries.

James A Angus1, Christine E Wright2.   

Abstract

Recent publications suggest that α1-adrenoceptor stimulation by exogenous agonists such as phenylephrine in resistance arteries cause contraction through the release of ATP from within the vascular smooth muscle cells. This ATP exits the cell through pannexin-1 channels to act back "autocrine-like" on P2 receptors on the smooth muscle that cause the contraction. In this work we directly test this hypothesis by using a selective P2X1 purinoceptor antagonist NF449 (1-10µM) against phenylephrine and ATP concentration-response curves in small mesenteric arteries of the rat and thoracodorsal arteries of the mouse. We show that NF449 is a simple competitive antagonist of ATP with a pKB of 6.43 and 6.41 in rat and mouse arteries, respectively, but did not antagonise phenylephrine concentration-response curves. This work cautions against the growing overstated role of the reputed pannexin-1/ATP release axis following α1-adrenoceptor activation in small resistance arteries.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP release; Adenosine triphosphate (PubChem CID: 5957); NF449; NF449 octasodium salt (PubChem CID: 6093161); P2X(1) receptors; Pannexin-1 channels; Phenylephrine; Phenylephrine hydrochloride (PubChem CID: 5284443); Vascular contraction; α(1)-adrenoceptors

Mesh:

Substances:

Year:  2015        PMID: 26593428     DOI: 10.1016/j.ejphar.2015.11.013

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  1 in total

1.  Response by Good et al to Letter Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone".

Authors:  Miranda E Good; Yu-Hsin Chiu; Ivan K H Poon; Iris Z Jaffe; Douglas A Bayliss; Brant E Isakson; Kodi S Ravichandran
Journal:  Circ Res       Date:  2018-05-25       Impact factor: 17.367

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.